跳至主要内容
临床试验/NCT03296761
NCT03296761Unknown不适用

Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury

Jingyuan,Xu1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2017年11月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
70
试验地点
1
主要终点
mortality

研究概览

简要总结

To observe the changes of plasma ESM-1 levels in patients with ARDS, and to explore its clinical significance.

详细描述

70 patients who diagnosed as ARDS were included in this study. Then keep blood samples from these patients in the first day, the third day and the seventh day, detect ESM-1 level in plasma by ELISA. Record Severity of illness and survival status of every patient within 28 days. Objective to evaluate the correlation between the level of ESM-1 in plasma and the prognosis of the patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted to ICU diagnosed of ARDS (Berlin definition)in 48h
  • Patients age between 18 years old and 80 years.
  • Exclusion Criteria:
  • Pregnant women,
  • Patients with malignant tumor,
  • Immunosuppression or immunocompromised patients.

排除标准

  • 未提供

结局指标

主要结局

mortality

时间窗: 28-day

次要结局

未报告次要终点

研究者

发起方
Jingyuan,Xu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jingyuan,Xu

chief doctor

Southeast University, China

研究点 (1)

Loading locations...

相似试验